SCHEMBL20461073

SCHEMBL20461073

CC1CCC(O[Si](C)(C)C(C)(C)C)C/C1=C\C=C1/CCC[C@@]2(C)[C@@H]1CC[C@@H]2[C@H](C)OCCC(C)(C)O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ VDR P11473 11/20 0.59
▸ MAPT P10636 2/20 0.46
▸ SREBF1 P36956 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ NR1I2 O75469 1/20 0.45
▸ ABCB11 O95342 1/20 0.45
▸ GC P02774 1/20 0.45
▸ PGR P06401 1/20 0.45
▸ ADORA3 P0DMS8 1/20 0.45
▸ RXRA P19793 1/20 0.45
▸ CHRM3 P20309 1/20 0.45
▸ CNR1 P21554 1/20 0.45
▸ SLC6A2 P23975 1/20 0.45
▸ HTR2C P28335 1/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ AGTR1 P30556 1/20 0.45
▸ SLC6A4 P31645 1/20 0.45
▸ ADRA1A P35348 1/20 0.45
▸ PTGS2 P35354 1/20 0.45
▸ OPRD1 P41143 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20461052 0.89 VDR (0.62) VDRMAPTSREBF1SMN1; SMN2NR1I2
SCHEMBL20461051 0.87 VDR (0.65) VDRMAPTSREBF1SMN1; SMN2NR1I2
SCHEMBL18023723 0.87 VDR (0.65) VDRMAPTSREBF1SMN1; SMN2NR1I2
SCHEMBL18021744 0.87 VDR (0.65) VDRMAPTSREBF1SMN1; SMN2NR1I2
SCHEMBL8091696 0.85 MEN1 (0.48) VDRMAPTSREBF1SMN1; SMN2NR1I2
SCHEMBL8091697 0.85 MEN1 (0.48) VDRMAPTSREBF1SMN1; SMN2NR1I2
SCHEMBL14107907 0.84 VDR (0.61) VDR
SCHEMBL10152624 0.84 VDR (0.59) VDR
SCHEMBL14107905 0.83 VDR (0.58) VDR
SCHEMBL23464432 0.83 VDR (0.69) VDRMAPTSREBF1SMN1; SMN2NR1I2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3056491-B1 SYNTHETIC INTERMEDIATE OF MAXACALCITOL, PREPARATION METHOD THEREFOR AND USE THEREOF ZHEJIANG HISUN PHARM CO LTD (CN) 2018-08-08 — — EP disclosed
Send feedback